First human test for new drug begins
NCT ID NCT07107802
Summary
This was a first-in-human study to check the safety and see how the body processes a new drug called ATX101. It involved 24 healthy adults who received a single dose of the drug or a placebo. The main goal was to see if the drug was safe and to measure its levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BlueClinical Phase I
Porto, 4250-449, Portugal
Conditions
Explore the condition pages connected to this study.